A Look Ahead: The Goal of Precision Medicine in Psoriatic Arthritis

Saakshi Khattri, MD


November 04, 2021

Rheumatology specialist Dr Saakshi Khattri traces the evolution of PsA treatments from nonsteroidal anti-inflammatories to the many currently approved options, including small-molecule oral treatments such as JAK inhibitors as well as injectable biologics. Dr Khattri also discusses the challenges of getting patients to achieve optimal results based on the course of their disease as well as economic considerations, plus her hopes that treating PsA will become "precision medicine."


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.